Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
65.49
+3.55 (5.73%)
May 22, 2026, 4:00 PM EDT - Market closed
Revenue by Geography
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | Mar '20 Mar 28, 2020 | Mar '19 Mar 30, 2019 | Mar '18 Mar 31, 2018 | Apr '17 Apr 1, 2017 | Apr '16 Apr 2, 2016 | Mar '15 Mar 28, 2015 | Mar '14 Mar 29, 2014 | Mar '13 Mar 30, 2013 |
|---|
| 982.18M | 1.01B | | | | | | | | | | | | |
United States Revenue Growth | -2.84% | 4.22% | | | | | | | | | | | | |
| 68.20M | 62.41M | | | | | | | | | | | | |
| 9.28% | 7.44% | | | | | | | | | | | | |
| 185.02M | 175.66M | | | | | | | | | | | | |
| 5.33% | 9.69% | | | | | | | | | | | | |
| 87.21M | 92.31M | | | | | | | | | | | | |
| -5.52% | -14.16% | | | | | | | | | | | | |
| 11.42M | 19.54M | | | | | | | | | | | | |
Other Geographic Revenue Growth | -41.55% | 47.09% | | | | | | | | | | | | |
| 3.00K | -6.00K | | | | | | | | | | | | |
| 1.33B | 1.36B | | | | | | | | | | | | |
| -1.97% | 3.95% | | | | | | | | | | | | |
Revenue Breakdown 2
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | Mar '20 Mar 28, 2020 | Mar '19 Mar 30, 2019 | Mar '18 Mar 31, 2018 | Apr '17 Apr 1, 2017 | Apr '16 Apr 2, 2016 | Mar '15 Mar 28, 2015 | Mar '14 Mar 29, 2014 | Mar '13 Mar 30, 2013 |
|---|
| 524.46M | 535.43M | | | | | | | | | | | | |
| -2.05% | -5.99% | | | | | | | | | | | | |
| 221.27M | 261.12M | | | | | | | | | | | | |
Blood Center Revenue Growth | -15.26% | -7.80% | | | | | | | | | | | | |
| 588.30M | 564.27M | | | | | | | | | | | | |
| 4.26% | 23.66% | | | | | | | | | | | | |
| 1.33B | 1.36B | | | | | | | | | | | | |
| -1.97% | 3.95% | | | | | | | | | | | | |
EBIT
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|
| Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | Mar '20 Mar 28, 2020 | Mar '19 Mar 30, 2019 | Mar '18 Mar 31, 2018 | Apr '17 Apr 1, 2017 | Apr '16 Apr 2, 2016 | Mar '15 Mar 28, 2015 | Mar '14 Mar 29, 2014 | Mar '13 Mar 30, 2013 |
|---|
Plasma Segment Operating Income (Post-Q3 2025 Reporting) | 184.80M | 184.51M | | | | | | | | | | | | |
Plasma Segment Operating Income (Post-Q3 2025 Reporting) Growth | 0.15% | 1.40% | | | | | | | | | | | | |
Blood Center Segment Operating Income (Post-Q3 2025 Reporting) | 49.98M | 52.82M | | | | | | | | | | | | |
Blood Center Segment Operating Income (Post-Q3 2025 Reporting) Growth | -5.38% | 24.65% | | | | | | | | | | | | |
Hospital Segment Operating Income (Post-Q3 2025 Reporting) | 103.74M | 88.98M | | | | | | | | | | | | |
Hospital Segment Operating Income (Post-Q3 2025 Reporting) Growth | 16.59% | 70.46% | | | | | | | | | | | | |
| 156.73M | 221.82M | | | | | | | | | | | | |
Operating Income (Total) Growth | -29.34% | 34.53% | | | | | | | | | | | | |
Updated May 7, 2026. Data Source:
Fiscal.ai.
